Background {#Sec1}
==========

Hematological reference values are necessary in routine assessments for diagnosis of blood disorders, infectious diseases, immune status, and diseases progression and also in assessment of response to antiretroviral treatment. Locally-derived age-specific hematological reference ranges were also recommended for proper patient managements and interpretation of results \[[@CR1]\].

In the use and interpretation of laboratory test results, it is important to understand the limitations of tests. These include the ability of the test to indicate the presence or absence of disease or whether the value in a report is normal or abnormal for a patient. These sounds the knowledge of reference value for a particular laboratory test is very crucial in patient management. The laboratory staff and those requesting tests should know the accepted reference ranges and clinical significance of the results of the quantitative tests performed in the laboratory. This will ensure that significantly abnormal results are detected, checked, reported, and acted on as soon as possible \[[@CR2]\].

There is a difference in reference ranges related to age, sex, geographic origin, altitude, and ethnic background in addition to hemoglobin abnormalities (thalassemia, sickle cell disease and hemoglobin C) or pathologic conditions (malaria, HIV and other viral infections) prevented to have one common hematological values for all countries \[[@CR2]--[@CR7]\]. Thus, the use of normal hematological values derived from other African countries could result in incorrect patient management in routine clinical care.

The reference intervals for analysis of hematological parameters during routine clinical activities in Ethiopia or Africa are reference texts generated from Caucasian adult populations living in developed countries \[[@CR8]\]. Lower values for hemoglobin, red blood cells, hematocrit, mean corpuscular volumes, platelets and neutrophils and higher monocytes and eosinophils levels were reported in African population compared to similar population in Western counter parts \[[@CR6], [@CR9]--[@CR12]\]. Also there are ample evidences that clinicians and medical researchers should use method-specific reference ranges in their laboratories which account for gender differences and variances in the ethnic composition of the local society \[[@CR13]\], but this is not done in developing countries.

An increasing number of clinical trials taking place in Africa are seeking to identify safe and effective prevention and treatment strategies to combat the heavy burden of infectious diseases in this region but there is only attempts to establish standard reference hematological intervals \[[@CR14]\], there is lack of well-established reference intervals.

In the absence of locally derived reference intervals, clinicians and researchers have to use reference values of western population's, thus it is important to establish local hematological reference intervals for appropriate diagnosis, treatment, and follow up of patients. The reference intervals that are currently used in Ethiopia are adopted from textbooks that refer mainly to Caucasian subjects. But one study in Ethiopia conducted in southeast Addis Ababa showed lower WBC and platelet values of healthy HIV negative Ethiopians than the adopted reference values \[[@CR15]\]. Thus, the main aim of this study was to establish locally derived hematological reference values that could be used in Northwest Ethiopia.

Methods {#Sec2}
=======

Study setting and population {#Sec3}
----------------------------

A cross sectional study was conducted from April to June 2014 at Gondar University Hospital blood banking center. The hospital is located in Gondar town which is 740 km from the capital of Ethiopia, Addis Ababa, in the Northwest of Ethiopia. The city has a latitude and longitude of 12°36′N and 37°28′E with an elevation of 2133 meters above sea level. Based on figures from the Central Statistical Agency of Ethiopia in 2007, Gondar has an estimated total population of 231,977. Gondar University Hospital is the only referral hospital with more than 400 beds for North West Ethiopia serving a population of about 5 million. The consecutive nonparametric method was based solely on the ranks of the observations (in order of magnitude) and ignores their measured values. According to the National Committee for Clinical Laboratory Standards (NCCLS), International Federation of Clinical Chemistry (IFCC) and Clinical Laboratory Standards Institute (CLIS) Guideline recommendations, a minimum size of 120 observations from each category is needed \[[@CR16]\]. Based on this guide line 120 male and 120 female study participants who pass the exclusion/inclusion criteria were selected conveniently. The reference individuals were selected based on medical examinations, current health status, blood pressure, taking any medication, working with hazardous chemicals, alcohol intake, presence of inherited health disorder in the family, tuberculosis, lymphadenopathy, weight loss, regular exercise, tobacco smoking, allergy manifestation, fever, malaria, HIV, hepatitis B virus surface antigen (HbsAg), hepatitis C virus antibodies (HcAbs), menstruation, pregnancy and use of contraceptives. After written informed consents were taken from study subjects, 4 ml of venous blood samples were collected immediately following the donation in tube containing EDTA and 4 ml bloods with plan tube for serological analysis was taken and proceed.

Laboratory investigation {#Sec4}
------------------------

About 4 ml of venous blood was collected by an experienced laboratory technologist from each subject for hematological parameters analysis. Hematological parameters; total white cell count (WBC), differential white cell count (neutrophils, lymphocytes, eosinophils, monocytes and basophiles), platelet count, red blood cell count (RBC), hemoglobin (Hgb), hematocrit (%), mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), and red cell distribution width (RDW) were determined using the automated blood analyzer Cell-Dyne 1800 (Abbott Laboratories Diagnostics Division, USA).The other 4 ml of blood after clotting the serum was separated and serological tests (HIV, HbsAg, and HcAbs) was assayed. Erythrocyte sedimentation rate (ESR) was done by using westerngreen method for 1 h.

Statistical analysis {#Sec5}
--------------------

Data was cleaned, edited, checked for completeness and entered into Epi-Info version 3.3.5 and then transferred to SPSS version 20 for statistical analysis. The mean, median and standard deviation of hematological reference intervals were determined using descriptive statistics. Mann--Whitney U test was used to determine reference intervals and also Harris and Boyd test was used to determine the reference intervals that need partition (Table [2](#Tab2){ref-type="table"}). The 95th percentile was taken as a reference interval.

Results {#Sec6}
=======

Socio demographic characteristics {#Sec7}
---------------------------------

A total of 120 male and 120 female adult healthy subjects from Gondar University Hospital Blood Bank Centre were included in this study. The mean age of the study subjects was 24.50 ± 6.65 years with age range from 18 to 50 years and about 69.6% were within age range of 18--25 years. From the study subjects 78.3% were living in Gondar town, 26.7% were married, 58.3% were students and 89.2% were orthodox in religion (Table [1](#Tab1){ref-type="table"}).Table 1The socio demographic characteristics of adult of Gondar participated in the studyVariablesSocio demographic characteristicsFrequencyPercentage (%)SexMale12050Female12050Age group (years)18--2516769.626--355121.2\>35229.2AddressGondar18878.9Around gondar5221.1Marital statusMarried6426.7Single17472.5Divorced20.8ReligionOrthodox21489.2Muslim229.2Protestant10.4Others31.2OccupationCivil servant218.8Private3615.0House wife62.5Farmer3715.4Students12058.3

Hematological reference interval {#Sec8}
--------------------------------

In order to determine hematological parameters that need combined or partition reference interval based on sex, Harris and Boyd test was used. Basing this test partitioned reference interval was determined for RBC, PCV, Hgb, MCH and MCHC (Table [2](#Tab2){ref-type="table"}). Median and 95th percentile of WBC, absolute neutrophils, absolute lymphocytes, absolute mixed cell, platelet, MCV, RDW and ESR were 5.1 (3.2--8.8 × 10^9^/l), 2.7 (1.6--5.1 × 10^9^/l), 1.9 (1--3.5 × 10^9^/l), 0.5 (0.2--1 × 10^9^/l), 264 (128--432 × 10^9^/l), 92 (85--100 fl); 14 (12--17%) and 5 (0--15 mm/h) respectively for the general population (Table [3](#Tab3){ref-type="table"}).Table 2Result of Harris and Boyd test, which was performed to see the need for partitioning of Reference interval based on sexParametersP valueHarris and BoydZ\*Z^†^DecisionWBC (×10^9^/l)0.377930.4No separate RINeutrophil (%)0.723930.6No separate RINeutrophils absolute (×10^9^/l)0.633130.01No separate RILymphocyte (%)0.675030.5No separate RILymphocytes absolute (×109/l)0.170530.9No separate RIMixed (%)0.537530.5No separate RIMixed absolute (×10^9^/l)0.278430.5No separate RIPlatelet (×10^9^/l)0.022332.3No separate RIRBC (×10^12^/l)*0.0016*33.4Separate RIHgb (g/dl)\<*0.0001*35.6Separate RIPCV (%)*0.0033*33.4Separate RIMCH (pg)*0.0016*33.1Separate RIMCHC (g/dl)\<*0.0001*35.0Separate RIMCV (fl)0.292930.3No separate RIRDW0.957730.6No separate RIESR (mm/h)0.328330.9No separate RIZ^†^ = critical value, Z\* = calculated value, Separate RI are needed only when Z^†^ is greater than Z\*, P value is derived from Mann--Whitney U testItalic values indicate hematological parameters which need partition between male and female (Z^†^ \> Z\*) Table 3Median, IQR, range and 95th percentile of reference interval, P values of hematological parameters for adult in Gondar, northwestern EthiopiaParametersNMedian (IQR)Range (min--max)RI (95th percentile)Lower limit 90% CIUpper limit 90% CIWBC (×10^9^/l)2405.1 (4.2--6.3)2.7--9.53.2--8.83.2 (2.9--3.5)8.8 (8.3--9.1)Neutrophil (%)24053 (48--58)30--7736--6936 (33.8--39.1)69 (66.9--76.5)Neutrophils absolute (×10^9^/l)2402.7 (2.1--3.5)1.3--7.31.6--5.11.6 (1.3--1.7)5.1 (4.6--6.2)Lymphocyte (%)24038 (33--42)17--5622--5522 (18.2--24.9)55 (52.4--55.9)Lymphocytes absolute (×109/l)2401.9 (1.5--2.3)0.70--5.01--3.51 (0.8--1.1)3.5 (3.2--4.2)Mixed (%)2409 (8--11)4--186--136 (5.4--6.4)13 (13.0--18.0)Mixed absolute (×10^9^/l)2400.50 (0.4--0.6)0.2--1.20.2--10.2 (0.2--0.3)1.0 (0.9--1.2)MCV (fl)24092 (90--94)78--10585--10085 (80.3--85.1)100 (99--102)Platelet (×10^9^/l)240264 (210--312)110--531128--432128 (115--140)432 (403--496)ESR (mm/h)2405.0 (0--5)0--200--150 (0--0)15 (15--20)RDW24014 (13--14)12--1812--1712 (12--12.7)17 (15.5--18.3)RBC (×10^12^/l) Male1205.01 (4.56--5.59)3.12--6.953.53--6.933.53 (3.12--3.9)6.93 (6.45--6.95) Female1204.8 (4.2--5.25)3.0--6.503.45--6.253.45 (3.0--3.57)6.25 (6.08--6.5)Hgb (g/dl) Male12014.2 (13.1--15.5)11.0--19.111.5--18.011.5 (11--11.9)18.0 (17.9--19.1) Female12012.9 (12.0--14.3)10.9--16.911.0--16.711.0 (10.9--11.3)16.7 (16.2--16.9)PCV (%) Male12046.9 (43.2--50.0)34.5--60.236.2--58.636.2 (34.5--37.6)58.6 (57.0--60.2) Female12045.2 (40.4--48)30.8--59.032.1--56.632.1 (30.8--36)56.6 (52.1--59)MCH (pg) Male12029.0 (28--30)26--34.026.6--33.326.6 (25.7--27.1)33.3 (32--34) Female12028.6 (27.7--29.2)25.6--33.125.8--32.825.8 (25.6--26.4)32.8 (31--33.1)MCHC (g/dl) Male12031.3 (30.6--32.4)28.0--36.529.5--34.429.5 (28--30)34.4 (33.6--36.5) Female12030.8 (30.0--31.2)28.0--34.728.5--34.428.5 (28--29)34.4 (32.5--34.7)

Box and Whisker plots indicate the effect of sex on hematological parameters of the study participants (Fig. [1](#Fig1){ref-type="fig"}). The median and 95th percentile reference intervals for RBC, Hgb, PCV, MCH and MCHC were 5.01 (3.53--6.93 × 10^12^/l), 46.9 (36.2--58.6%), 14.2 (11.5--18 g/dl) and 31.3 (29.5--34.4 g/dl) respectively for males and 4.8 (3.45--6.25 × 10^12^/l), 45.2 (32.1--56.6%), 12.9 (11--16 g/dl) and 30.8 (28.5--34.4 g/dl) respectively for females (Table [3](#Tab3){ref-type="table"}).Fig. 1*Box* and *Whisker plots* indicating the effect of sex on hematological parameters of the study participants. **a** Red blood cells, **b** Hemoglobin, **c** Hematocrit, **d** Mean corpuscular hemoglobin, **e** Mean corpuscular hemoglobin concentration

Discussion {#Sec9}
==========

This study showed a significant gender differences for the RBC parameters (RBC, Hgb, PCV, MCH and MCHC). The finding agrees with the well-established fact that males have higher values than female. While there was no significant differences between genders with regard to WBC parameters, platelet counts, ESR, MCV and RDW. This was also in agreement with previously carried out studies in Addis Ababa and other African countries \[[@CR1], [@CR6], [@CR15], [@CR17]--[@CR19]\] (Tables [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}). The significant difference between male and female may be due to biological and physiological factors such as the influence of the hormone androgen on erythropoiesis and also due to menstrual blood loss in femalesTable 4Comparison of median, 95% reference range and Mean ± SD of hematological parameters in this study and othersParameterGondar (current study)Addis Ababa \[[@CR17]\]Kenya \[[@CR6]\]Burkina Faso (22)Wintrobe \[[@CR2]\]SexMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDWBC (×10^9^)Female5.1 (3.2--8.8)5.3 ± 1.45.9 (3--12.2)6.2 ± 2.24.9 (3.0--9.1)NA5.2 (3.4--7.4)NANA (4.3--10)7.2 ± NAMale5.9 (3--9.8)6.0 ± 1.84.3 (2.7--7.5)NA5.1 (3.2--9.2)NANA (4.3--100)7.2 ± NAPlatelet (×10^9^)Female264 (128--432)267 ± 76193 (98--352)202 ± 67251 (124--444)NA252 (159--356)NANA (150--450)NAMale203 (97--324)207 ± 62218 (115--366)NA217 (127--365)NANA (150--450)NANeutrophil (absolute) (×10^9^)Female2.7 (1.6--5.1)2.8 ± 0.9NANA1.96 (0.99--5.6)NANANANANAMaleNANA1.78 (0.88--4.3)NANANANANANeutrophil (%)Female53 (36--69)53 ± 8NANA42 (20--70)NA46 (30--62)NANANAMaleNANA42 (20--70)NA43 (27--64)NANANALymphocyte (absolute) (×10^9^)Female1.9 (1--3.5)2 ± 0.71.7 (1.09--3.5)NA2.16 (1.29--4.0)NA2.2 (1.4--3.2)NANANAMale(0.96--3.5)NA1.86 (1.12--3.2)NA2.1 (1.3--4.0)NANANALymphocyte (%)Female38 (22--55)37 ± 8(17--59)36 ± NA45 (20--60)NA43 (27--57)NANANAMale(17--59)36 ± NA45 (20--60)NA44 (26--60)NANANAMix cells (absolute) (×109)Female0.5 (0.2--1)0.5 ± 0.2NANANANANANANANAMaleNANANANANANANANAMixed cells (%)Female9 (6--13)10 ± 2NANANANANANANANAMaleNANANANANANANANA*WBC* white blood cells, *SD* standard deviation, *NA* not applicable Table 5Comparison of median, 95% reference range and Mean ± SD of hematological parameters in this study and othersParameterGondar (current study)Addis Ababa \[[@CR17]\]Kenya \[[@CR6]\]Burkina Faso (22)Wintrobe \[[@CR2]\]Median (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDMedian (95% range)Mean ± SDRBC (×10^12^) Female4.8 (3.45--6.25)4.7 ± 0.7254.5 (3.7--5.2)4.5 ± 0.44.8 (3.7--5.6)NA4.2 (3.5--4.9)NANA (4.2--5.5)4.8 ± NA Male5.01 (3.53-6.93)0.09 ± 0.795 (4.3--5.9)5.1 ± 0.45.3 (4.4--6.3)NA4.7 (3.8--5.6)NANA (4.5--6.3)5.4 ± NAPCV (%) Female45.2 (32.1--56.6)44.2 ± 5.8442.1 (35.3--48.8)42 ± 3.240 (30--50)NA35 (30--39)NANA (37--47)42 ± NA Male46.9 (36.2--58.6)6.8 ± 5.848.2 (41.6--55.11)48.3 ± 3.747 (40--50)NA39 (34--46)NANA (41--51)46 ± NAHgb (g/dl) Female12.9 (11--16.7)13.2 ± 1.614.9 (12.2--16.6)14.3 ± 3.48.44 (5.9--10)NA12 (9.8--13.5)NANA (12--16)14 ± NA Male14.2 (11.5--18)14.4 ± 1.816.1 (13.9--18.3)16.1 ± 1.19.9 (8.3--11.3)NA13.5 (11.3--15.6)NANA (14--18)16 ± NAMCV (fl**)** Female92 ± 3.7NANA84.9 (66--95.7)NA84 (75--92)NANANA Male92 (85 --100)NANA88 (71.4--98.2)NA85 (73--94)NANANAMCH (pg) Female28.6 (25.8--32.8)28.5 ± 1.46NANANANA28 (24--32)NANANA Male29 (26.6--33.3)29.1 ± 1.54NANANANA29 (25--34)NANANAMCHC (g/dl) Female30.8 (28.5--34.4)30.6 ± 1.2NANA33.9 (32.2--35.2)NA34.2 (31.4--36.1)NANANA Male31.3 (29.5--34.4)31.5 ± 1.3NANA34.2 (32.4--35.3)NA34.6 (31.7--36.3)NANANA Table 6Comparisons of median and 95% reference range with Eastern and Southern Africa (18), Tanzania (19), Togo (20) and Uganda (21) of African countriesParametersGondarTogoTanzaniaUgandaEastern and southern AfricaMedian (95% range)Median (95% range)Median (95% range)Median (95% range)Median (95% range)WBC (×10^9^/l)5.1 (3.2--8.8)4.1 (1.9--10.1)4.6 (3.0--7.9)4.9 (2.8--8.2)3.1--9.1Neutrophils (Abs)2.7 (1.6--5.1)1.6 (0.5--5.4)2.2 (1.1--4.7)NA1.0--5.3Neutrophils (%)53 (36--69)NA48.1 (32.0--69.1)38.9 (22.2--59.3)25--66Lymphocyte (Abs)1.9 (1--3.5)2.1 (1.1--4.3)1.8 (1.1--3.0)NA1.2--3.7Lymphocyte (%)38 (22--55)NA40.5 (20.8--56.7)44.4 (26.7--61.2)23--59Mixed (Abs)0.5 (0.2--1)NA0.5 (0.3--1.1)NANAMixed (%)9 (6--13)NA10.3 (5.6--19.8)NANAPlatelet (×10^9^/l)264 (128--432)239 (120--443)244 (150--398)218.5 (109--384)126--438MCV (fl)92 (85--100)84.5 (80--99)89.4 (77.6--98.1)85 (71--97)68--98RBC (×10^12^/l) Male4.8 (3.45--6.25) 5.05.0 (3.3--6.4)5.21 (4.41--6.27)5.0 (3.8--6.1)4.0--6.4 Female1 (3.53--6.93)4.5 (3.1--6.0)4.69 (3.84--5.59)4.4 (3.3--5.3)3.8--5.6Hgb (g/dl) Male12.9 (11--16.7)15.8 (10.0--18.4)15.4 (13.7--17.7)14.5 (11.6--17.1)12.2--17.7 Female14.2 (11.5--18)13.0 (10.3--17.1)13.5 (11.1--15.7)12.8 (9.8--16.2)9.5--15.8PCV (%) Male45.2 (32.1--56.6)42.8 (28.0--54.0)46.6 (40.2--53.7)42.6 (33.8--49.5)35.0--50.8 Female46.9 (36.2--58.6)38.1 (28.0--47.0)41.5 (36.2--46.8)37.8 (28.3--46.8)29.4--45.4MCH (pg) Male28.6 (25.8--32.8)29.7 (26--36)30.0 (23.1--33.2)29.2 (23.0--33.8)NA Female29 (26.6--33.3)29.3 (25--37)29.3 (24.2--33.1)29.5 (24.8--32.7)NAMCHC (%) Male30.8 (28.5--34.4)35.1 (29--39)33.3 (30.6--35.1)34.2 (32.4--35.3)NA Female31.3 (29.5--34.4)35.1 (30--41)32.7 (30.4--34.8)34.2 (33.0--35.5)NARDW (%) Male14 (12--17)NANA12.8 (10.9--16.8)NA Female14 (12--17)NANA12.7 (11.0--17.3)NA*Abs* absolute

The 95th percentile reference interval of the current study lower limit of RBC in both sexes, were lower than studies conducted in Addis Ababa Ethiopia, Kenya, Burkina Faso and text books while the upper limit was higher than the above mentioned studies (Tables [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}). Comparison of hematological results with this study indicated that similarity could not be found based on geographical proximity, this may be due to difference in altitude, method and instrument used for analysis \[[@CR6], [@CR8], [@CR15], [@CR18]\].

The lower limit of hemoglobin reference interval in this study was lower than a study conducted in Addis Ababa and text books while higher than studies conducted in Kenya and Burkina Faso for both genders. On the other hand the upper limit of Hgb was higher than Addis Ababa, text books, Kenya, and Burkina Faso. This difference may be due to altitude and ethnic variations. Thus, it may not be possible, even, to have one standard reference between two localities in the same county as experienced in Kenya. Similarly the lower limit reference intervals of PCV in both sexes was lower than study conducted in Addis Ababa, text books and higher than studies conducted in Kenya and Burkina Faso. While the upper limit was higher than studies carried out in Addis Ababa, Kenya, Burkina Faso and text books \[[@CR6], [@CR8], [@CR15], [@CR18]\]. Likewise of RBC and Hgb the difference in the reference interval values might arise from differences in altitude and ethnical variations.

The current study reference interval values of MCV are generally higher than values indicated in different African countries. The lower limit values of MCH in both sexes in this study was higher than a study conducted in Burkina Faso, but the upper limit was comparable, but the established values of MCHC in both sexes was generally lower than values indicated in different African countries \[[@CR6], [@CR18]\]. The WBCs reference intervals established for the general population in the current study was lower than the values described for Caucasian population in different text books, Addis Ababa, Burkina Faso and Kenya. However, median and 95 percentile ranges of neutrophils and lymphocytes of this study compared with similar study conducted on Caucasian, African, Afro-Caribbean and Jamaican population, neutrophils were lower than Caucasian and Afro-Caribbean, but higher than African and Jamaica. Lymphocyte count in the current study was higher than Caucasian and African black population \[[@CR6], [@CR8], [@CR15], [@CR18]\]. The difference between the current result and other findings might be due to geographical differences, environment, diet, and ethnic background \[[@CR16]\].

The median and 95th percentile range values of ESR was at normal range with no difference for male and female as all the recruited subjects were healthy, not exposed to inflammatory conditions associated with systemic inflammatory diseases \[[@CR20]\].

Conclusions {#Sec10}
===========

Haematological reference intervals established from adult healthy population of Northwest Ethiopia (Gondar and surrounding areas) were different from Caucasian and African counties. The haematological intervals were also different from previous results obtained in other part of Ethiopia. Intervals for red blood cell count, hematocrit values, hemoglobin concentration, MCH and MCHC were different for male and female but there was no difference in WBC parameters, PLT, MCV, RDW and ESR.Further studies on haematological intervals for all age groups are recommended for locally derived standard haematological intervals (Additional file [1](#MOESM1){ref-type="media"}).

Additional file {#Sec11}
===============

**Additional file 1.** Questionnaire for data collection of a study on Hematological reference intervals determination in adults at Gondar university hospital, Northwest Ethiopia.

AIDS

:   acquired immune deficiency syndrome

BMI

:   body mass index

CLSI

:   Clinical Laboratory Standard Institution

EDTA

:   ethylene diamine tetra-acetic acid

HbsAgs

:   hepatitis B virus surface antigen

HcAbs

:   hepatitis C virus antibodies

Hgb

:   hemoglobin

HIV

:   human immunodeficiency virus

IFCC

:   International Federation of Clinical Chemistry

LPT

:   lymphocyte

MCH

:   mean corpuscular hemoglobin

MCHC

:   mean corpuscular hemoglobin concentration

MCV

:   mean corpuscular volume

NCCLS

:   National Committee for Clinical Laboratory Standards

NTL

:   neutrophils

PCV

:   packed cell volume

PLT

:   platelet

RBC

:   red blood cells

RDW

:   red cell distribution width

RIs

:   reference intervals

WBC

:   white blood cells

AY: Recruited the patients, collected and analyzed the data and wrote the draft of the manuscript. BE: Conceived the study, obtained ethics papers, supervised the collection of data and revised the draft. BT: Involve in proposal development, data collection and entry for analysis. MA: Interpreted the collected data and wrote the draft along with BE. All authors read and approved the final manuscript.

Acknowledgements {#FPar1}
================

The authors would like to extend their appreciation to Gondar University Hospital, Blood banking and ART laboratory professionals for their help in the collection, processing and analyzing of laboratory tests and University of Gondar for giving this opportunity to conduct this study. Also authors want to express their great thanks to the study participants for their patience and cooperation.

Competing interests {#FPar2}
===================

The authors declare that they have no competing interests.

Availability of data and material {#FPar3}
=================================

The datasets during and/or analyzed during the current study available from the corresponding author on reasonable request.

Ethics approval and consent to participate {#FPar4}
==========================================

The study was conducted after ethical approval was obtained from University of Gondar, School of Biomedical and Laboratory Sciences Ethical Committee. Informed written consent was taken from study participants before enrollment in the study. Then the objective of this research was explained to the study participants. Those willing to participate were included. Participation in the study was voluntary blood donors and refusal was possible. To ensure confidentiality of data, study subjects were identified using codes and unauthorized persons were not able to access the collected data. The study participants' serological results were reported by blood banking manager to the physician for proper management and counseling.
